ClinicalTrials.Veeva

Menu

Tension-Type Headache Gene Expression and Methylation (TTH)

U

University of Gaziantep

Status

Conditions

Tension-Type Headache, Unspecified, Intractable

Treatments

Genetic: Peripheral blood sampling

Study type

Expanded Access

Funder types

Other

Identifiers

NCT06562855
GaziantepUniversity

Details and patient eligibility

About

Tension-type headache (TTH) refers to pain radiating from the forehead to the back of the head as a bilateral band. It often occurs without warning and spreads to the neck muscles. Patients describe it as tension, pressure, or dull pain. It is usually triggered by stress. The complexity of the processes is the biggest difficulty in diagnosing and treating TTH. Although there are genetic connections, there are no single responsible genes.

Full description

130 TTH patients and 117 healthy controls were included in the study. Serum markers of the patients were measured. WNT5A, responsible for the Wnt-B catenin signaling pathway, and its receptor FZD3 were examined in the pathogenesis of TTH. Expression changes and methylation profiles of genes were obtained. Genetic and serum parameters were compared. Diagnostic powers were determined by ROC analyses.

Sex

All

Ages

17 to 82 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • (ICHD)-3 criteria
  • Male and female
  • 17-82 years
  • not diagnosed with tension-type or other primary headaches

Exclusion criteria

  • Tension-type headache not diagnosed
  • below 16 ages
  • pregnant woman
  • subdural hematoma
  • intracranial mass

Trial contacts and locations

2

Loading...

Central trial contact

Şenay Görücü Yılmaz, PhD; Sırma Geyik, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems